UBTF and breast carcinoma: Overall, these findings indicate that the inhibition of 45S pre-rRNA and UBF by melatonin is critically involved in the synergistic antitumor effect by combined treatment of melatonin and puromycin in aggressive MDA-MB 231 breast cancer cells and suggest melatonin has cancer chemotherapeutic potential in breast cancer cells.